APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Corticosteroid

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhaled Corticosteroid Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchInhaled Corticosteroid Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Corticosteroid Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Inhaled Corticosteroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Corticosteroid Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Corticosteroid Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Inhaled Corticosteroid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhaled Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhaled Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhaled Corticosteroid include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GSK, Amgen and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhaled Corticosteroid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhaled Corticosteroid market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhaled Corticosteroid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhaled Corticosteroid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhaled Corticosteroid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhaled Corticosteroid Market by Company

Teva Pharmaceutical

Sanofi

Johnson and Johnson

Novartis

Merck

Pfizer

GSK

Amgen

AstraZeneca

Teijin

Sumitomo

Kos Pharmaceutical

Glaxo's Advair

Inhaled Corticosteroid Segment by Type

Mometasone

Fluticasone Inhaler Powder

Budesonide

Beclomethasone Dipropionate

Others

Inhaled Corticosteroid Segment by Application

Respiratory Care Centers

Hospitals

Clinics

Others

Inhaled Corticosteroid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Corticosteroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Corticosteroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Corticosteroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaled Corticosteroid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhaled Corticosteroid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mometasone Table 2. Major Company of Fluticasone Inhaler Powder Table 3. Major Company of Budesonide Table 4. Major Company of Beclomethasone Dipropionate Table 5. Major Company of Others Table 6. Global Inhaled Corticosteroid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 8. Global Inhaled Corticosteroid Sales Market Share in Volume by Type (2021-2026) Table 9. Global Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 10. Global Inhaled Corticosteroid Sales Market Share in Value by Type (2021-2026) Table 11. Global Inhaled Corticosteroid Price by Type (2021-2026) & (US$/Ton) Table 12. Global Inhaled Corticosteroid Sales by Type (2027-2032) & (Tons) Table 13. Global Inhaled Corticosteroid Sales Market Share in Volume by Type (2027-2032) Table 14. Global Inhaled Corticosteroid Sales by Type (2027-2032) & (US$ Million) Table 15. Global Inhaled Corticosteroid Sales Market Share in Value by Type (2027-2032) Table 16. Global Inhaled Corticosteroid Price by Type (2027-2032) & (US$/Ton) Table 17. North America Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 18. North America Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 20. Europe Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 22. Asia-Pacific Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 24. Latin America Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Inhaled Corticosteroid Sales by Type (2021-2026) & (Tons) Table 26. Middle East and Africa Inhaled Corticosteroid Sales by Type (2021-2026) & (US$ Million) Table 27. Inhaled Corticosteroid Industry Trends Table 28. Inhaled Corticosteroid Industry Drivers Table 29. Inhaled Corticosteroid Industry Opportunities and Challenges Table 30. Inhaled Corticosteroid Industry Restraints Table 31. Global Inhaled Corticosteroid Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Inhaled Corticosteroid Revenue Market Share by Company (2021-2026) Table 33. Global Inhaled Corticosteroid Sales by Company (2021-2026) & (Tons) Table 34. Global Inhaled Corticosteroid Sales Share by Company (2021-2026) Table 35. Global Inhaled Corticosteroid Market Price by Company (2021-2026) & (US$/Ton) Table 36. Global Inhaled Corticosteroid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Inhaled Corticosteroid Major Company Production Sites and Headquarters Table 38. Global Inhaled Corticosteroid Company, Product Type & Application Table 39. Global Inhaled Corticosteroid Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Inhaled Corticosteroid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Inhaled Corticosteroid Sales by Region (2021-2026) & (Tons) Table 44. Global Inhaled Corticosteroid Sales Market Share in Volume by Region (2021-2026) Table 45. Global Inhaled Corticosteroid Sales by Region (2021-2026) & (US$ Million) Table 46. Global Inhaled Corticosteroid Sales Market Share in Value by Region (2021-2026) Table 47. Global Inhaled Corticosteroid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Global Inhaled Corticosteroid Sales by Region (2027-2032) & (Tons) Table 49. Global Inhaled Corticosteroid Sales Market Share in Volume by Region (2027-2032) Table 50. Global Inhaled Corticosteroid Sales by Region (2027-2032) & (US$ Million) Table 51. Global Inhaled Corticosteroid Sales Market Share in Value by Region (2027-2032) Table 52. Global Inhaled Corticosteroid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 53. Global Inhaled Corticosteroid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 55. Global Inhaled Corticosteroid Sales Market Share in Volume by Application (2021-2026) Table 56. Global Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 57. Global Inhaled Corticosteroid Sales Market Share in Value by Application (2021-2026) Table 58. Global Inhaled Corticosteroid Price by Application (2021-2026) & (US$/Ton) Table 59. Global Inhaled Corticosteroid Sales by Application (2027-2032) & (Tons) Table 60. Global Inhaled Corticosteroid Sales Market Share in Volume by Application (2027-2032) Table 61. Global Inhaled Corticosteroid Sales by Application (2027-2032) & (US$ Million) Table 62. Global Inhaled Corticosteroid Sales Market Share in Value by Application (2027-2032) Table 63. Global Inhaled Corticosteroid Price by Application (2027-2032) & (US$/Ton) Table 64. North America Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 65. North America Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 67. Europe Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 69. Asia-Pacific Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 71. Latin America Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Inhaled Corticosteroid Sales by Application (2021-2026) & (Tons) Table 73. Middle East and Africa Inhaled Corticosteroid Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Company Information Table 75. Teva Pharmaceutical Business Overview Table 76. Teva Pharmaceutical Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Inhaled Corticosteroid Product Portfolio Table 78. Teva Pharmaceutical Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Sanofi Inhaled Corticosteroid Product Portfolio Table 83. Sanofi Recent Development Table 84. Johnson and Johnson Company Information Table 85. Johnson and Johnson Business Overview Table 86. Johnson and Johnson Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Johnson and Johnson Inhaled Corticosteroid Product Portfolio Table 88. Johnson and Johnson Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Novartis Inhaled Corticosteroid Product Portfolio Table 93. Novartis Recent Development Table 94. Merck Company Information Table 95. Merck Business Overview Table 96. Merck Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Merck Inhaled Corticosteroid Product Portfolio Table 98. Merck Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Pfizer Inhaled Corticosteroid Product Portfolio Table 103. Pfizer Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. GSK Inhaled Corticosteroid Product Portfolio Table 108. GSK Recent Development Table 109. Amgen Company Information Table 110. Amgen Business Overview Table 111. Amgen Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Amgen Inhaled Corticosteroid Product Portfolio Table 113. Amgen Recent Development Table 114. AstraZeneca Company Information Table 115. AstraZeneca Business Overview Table 116. AstraZeneca Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. AstraZeneca Inhaled Corticosteroid Product Portfolio Table 118. AstraZeneca Recent Development Table 119. Teijin Company Information Table 120. Teijin Business Overview Table 121. Teijin Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Teijin Inhaled Corticosteroid Product Portfolio Table 123. Teijin Recent Development Table 124. Sumitomo Company Information Table 125. Sumitomo Business Overview Table 126. Sumitomo Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Sumitomo Inhaled Corticosteroid Product Portfolio Table 128. Sumitomo Recent Development Table 129. Kos Pharmaceutical Company Information Table 130. Kos Pharmaceutical Business Overview Table 131. Kos Pharmaceutical Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 132. Kos Pharmaceutical Inhaled Corticosteroid Product Portfolio Table 133. Kos Pharmaceutical Recent Development Table 134. Glaxo's Advair Company Information Table 135. Glaxo's Advair Business Overview Table 136. Glaxo's Advair Inhaled Corticosteroid Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 137. Glaxo's Advair Inhaled Corticosteroid Product Portfolio Table 138. Glaxo's Advair Recent Development Table 139. North America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 140. North America Inhaled Corticosteroid Sales by Country (2021-2026) & (Tons) Table 141. North America Inhaled Corticosteroid Sales Market Share by Country (2021-2026) Table 142. North America Inhaled Corticosteroid Sales Forecast by Country (2027-2032) & (Tons) Table 143. North America Inhaled Corticosteroid Sales Market Share Forecast by Country (2027-2032) Table 144. North America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. North America Inhaled Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 146. North America Inhaled Corticosteroid Market Share by Country (2021-2026) Table 147. North America Inhaled Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. North America Inhaled Corticosteroid Market Share Forecast by Country (2027-2032) Table 149. Europe Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 150. Europe Inhaled Corticosteroid Sales by Country (2021-2026) & (Tons) Table 151. Europe Inhaled Corticosteroid Sales Market Share by Country (2021-2026) Table 152. Europe Inhaled Corticosteroid Sales Forecast by Country (2027-2032) & (Tons) Table 153. Europe Inhaled Corticosteroid Sales Market Share Forecast by Country (2027-2032) Table 154. Europe Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Europe Inhaled Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 156. Europe Inhaled Corticosteroid Market Share by Country (2021-2026) Table 157. Europe Inhaled Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Europe Inhaled Corticosteroid Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Inhaled Corticosteroid Sales by Country (2021-2026) & (Tons) Table 161. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Country (2021-2026) Table 162. Asia-Pacific Inhaled Corticosteroid Sales Forecast by Country (2027-2032) & (Tons) Table 163. Asia-Pacific Inhaled Corticosteroid Sales Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Inhaled Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 166. Asia-Pacific Inhaled Corticosteroid Market Share by Country (2021-2026) Table 167. Asia-Pacific Inhaled Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Asia-Pacific Inhaled Corticosteroid Market Share Forecast by Country (2027-2032) Table 169. Latin America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 170. Latin America Inhaled Corticosteroid Sales by Country (2021-2026) & (Tons) Table 171. Latin America Inhaled Corticosteroid Sales Market Share by Country (2021-2026) Table 172. Latin America Inhaled Corticosteroid Sales Forecast by Country (2027-2032) & (Tons) Table 173. Latin America Inhaled Corticosteroid Sales Market Share Forecast by Country (2027-2032) Table 174. Latin America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Latin America Inhaled Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 176. Latin America Inhaled Corticosteroid Market Share by Country (2021-2026) Table 177. Latin America Inhaled Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Latin America Inhaled Corticosteroid Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Inhaled Corticosteroid Sales by Country (2021-2026) & (Tons) Table 181. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Country (2021-2026) Table 182. Middle East and Africa Inhaled Corticosteroid Sales Forecast by Country (2027-2032) & (Tons) Table 183. Middle East and Africa Inhaled Corticosteroid Sales Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Inhaled Corticosteroid Market Size by Country (2021-2026) & (US$ Million) Table 186. Middle East and Africa Inhaled Corticosteroid Market Share by Country (2021-2026) Table 187. Middle East and Africa Inhaled Corticosteroid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Middle East and Africa Inhaled Corticosteroid Market Share Forecast by Country (2027-2032) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Inhaled Corticosteroid Distributors List Table 192. Inhaled Corticosteroid Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Inhaled Corticosteroid Image Figure 2. Global Inhaled Corticosteroid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled Corticosteroid Sales (2021-2032) & (Tons) Figure 5. Mometasone Image Figure 6. Global Mometasone Sales YoY Growth (2021-2032) & (Tons) Figure 7. Fluticasone Inhaler Powder Image Figure 8. Global Fluticasone Inhaler Powder Sales YoY Growth (2021-2032) & (Tons) Figure 9. Budesonide Image Figure 10. Global Budesonide Sales YoY Growth (2021-2032) & (Tons) Figure 11. Beclomethasone Dipropionate Image Figure 12. Global Beclomethasone Dipropionate Sales YoY Growth (2021-2032) & (Tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 15. Global Inhaled Corticosteroid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Inhaled Corticosteroid Market Share by Type 2025 VS 2032 Figure 17. North America Inhaled Corticosteroid Sales Market Share in Volume by Type in 2025 Figure 18. North America Inhaled Corticosteroid Sales Market Share in Value by Type in 2025 Figure 19. Europe Inhaled Corticosteroid Sales Market Share in Volume by Type in 2025 Figure 20. Europe Inhaled Corticosteroid Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Inhaled Corticosteroid Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Inhaled Corticosteroid Sales Market Share in Value by Type in 2025 Figure 23. Latin America Inhaled Corticosteroid Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Inhaled Corticosteroid Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Inhaled Corticosteroid Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Inhaled Corticosteroid Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Inhaled Corticosteroid Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Respiratory Care Centers Image Figure 30. Global Respiratory Care Centers Sales YoY Growth (2021-2032) & (Tons) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (Tons) Figure 33. Clinics Image Figure 34. Global Clinics Sales YoY Growth (2021-2032) & (Tons) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 37. Global Inhaled Corticosteroid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Inhaled Corticosteroid Market Share by Application 2025 VS 2032 Figure 39. North America Inhaled Corticosteroid Sales Market Share in Volume by Application in 2025 Figure 40. North America Inhaled Corticosteroid Sales Market Share in Value by Application in 2025 Figure 41. Europe Inhaled Corticosteroid Sales Market Share in Volume by Application in 2025 Figure 42. Europe Inhaled Corticosteroid Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Inhaled Corticosteroid Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Inhaled Corticosteroid Sales Market Share in Value by Application in 2025 Figure 45. Latin America Inhaled Corticosteroid Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Inhaled Corticosteroid Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Inhaled Corticosteroid Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Inhaled Corticosteroid Sales Market Share in Value by Application in 2025 Figure 49. North America Inhaled Corticosteroid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. North America Inhaled Corticosteroid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Inhaled Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Inhaled Corticosteroid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Europe Inhaled Corticosteroid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Inhaled Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Inhaled Corticosteroid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Asia-Pacific Inhaled Corticosteroid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Inhaled Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Inhaled Corticosteroid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Latin America Inhaled Corticosteroid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Inhaled Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Inhaled Corticosteroid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 66. Middle East and Africa Inhaled Corticosteroid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Inhaled Corticosteroid Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Inhaled Corticosteroid Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Inhaled Corticosteroid Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Mometasone
  • Fluticasone Inhaler Powder
  • Budesonide
  • Beclomethasone Dipropionate
  • Others
Applications
  • Respiratory Care Centers
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Merck
  • Pfizer
  • GSK
  • Amgen
  • AstraZeneca
  • Teijin
  • Sumitomo
  • Kos Pharmaceutical
  • Glaxo's Advair

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaled Corticosteroid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhaled Corticosteroid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhaled Corticosteroid Market by Type
  6. 1.3.1 Mometasone
  7. 1.3.2 Fluticasone Inhaler Powder
  8. 1.3.3 Budesonide
  9. 1.3.4 Beclomethasone Dipropionate
  10. 1.3.5 Others
  11. 1.4 Global Inhaled Corticosteroid Market Size by Type
  12. 1.4.1 Global Inhaled Corticosteroid Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Inhaled Corticosteroid Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Inhaled Corticosteroid Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Inhaled Corticosteroid Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Inhaled Corticosteroid Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Inhaled Corticosteroid Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Inhaled Corticosteroid Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Inhaled Corticosteroid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhaled Corticosteroid Industry Trends
  2. 2.2 Inhaled Corticosteroid Industry Drivers
  3. 2.3 Inhaled Corticosteroid Industry Opportunities and Challenges
  4. 2.4 Inhaled Corticosteroid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhaled Corticosteroid Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhaled Corticosteroid Sales (2021-2026)
  3. 3.3 Global Top Players by Inhaled Corticosteroid Price (2021-2026)
  4. 3.4 Global Inhaled Corticosteroid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaled Corticosteroid Major Company Production Sites & Headquarters
  6. 3.6 Global Inhaled Corticosteroid Company, Product Type & Application
  7. 3.7 Global Inhaled Corticosteroid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaled Corticosteroid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaled Corticosteroid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaled Corticosteroid Tier 1, Tier 2, and Tier 3
4 Inhaled Corticosteroid Regional Status and Outlook
  1. 4.1 Global Inhaled Corticosteroid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhaled Corticosteroid Historic Market Size by Region
  3. 4.2.1 Global Inhaled Corticosteroid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhaled Corticosteroid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhaled Corticosteroid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhaled Corticosteroid Forecasted Market Size by Region
  7. 4.3.1 Global Inhaled Corticosteroid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhaled Corticosteroid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhaled Corticosteroid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhaled Corticosteroid by Application
  1. 5.1 Inhaled Corticosteroid Market by Application
  2. 5.1.1 Respiratory Care Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Inhaled Corticosteroid Market Size by Application
  7. 5.2.1 Global Inhaled Corticosteroid Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Inhaled Corticosteroid Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Inhaled Corticosteroid Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Inhaled Corticosteroid Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Inhaled Corticosteroid Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Inhaled Corticosteroid Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Inhaled Corticosteroid Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Inhaled Corticosteroid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Inhaled Corticosteroid Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Inhaled Corticosteroid Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson and Johnson
  14. 6.3.1 Johnson and Johnson Company Information
  15. 6.3.2 Johnson and Johnson Business Overview
  16. 6.3.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson and Johnson Inhaled Corticosteroid Product Portfolio
  18. 6.3.5 Johnson and Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Inhaled Corticosteroid Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Inhaled Corticosteroid Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inhaled Corticosteroid Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Inhaled Corticosteroid Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Amgen
  44. 6.8.1 Amgen Company Information
  45. 6.8.2 Amgen Business Overview
  46. 6.8.3 Amgen Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Inhaled Corticosteroid Product Portfolio
  48. 6.8.5 Amgen Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Inhaled Corticosteroid Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Teijin
  56. 6.10.1 Teijin Company Information
  57. 6.10.2 Teijin Business Overview
  58. 6.10.3 Teijin Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teijin Inhaled Corticosteroid Product Portfolio
  60. 6.10.5 Teijin Recent Developments
  61. 6.11 Sumitomo
  62. 6.11.1 Sumitomo Company Information
  63. 6.11.2 Sumitomo Business Overview
  64. 6.11.3 Sumitomo Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sumitomo Inhaled Corticosteroid Product Portfolio
  66. 6.11.5 Sumitomo Recent Developments
  67. 6.12 Kos Pharmaceutical
  68. 6.12.1 Kos Pharmaceutical Company Information
  69. 6.12.2 Kos Pharmaceutical Business Overview
  70. 6.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kos Pharmaceutical Inhaled Corticosteroid Product Portfolio
  72. 6.12.5 Kos Pharmaceutical Recent Developments
  73. 6.13 Glaxo's Advair
  74. 6.13.1 Glaxo's Advair Company Information
  75. 6.13.2 Glaxo's Advair Business Overview
  76. 6.13.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Glaxo's Advair Inhaled Corticosteroid Product Portfolio
  78. 6.13.5 Glaxo's Advair Recent Developments
7 North America by Country
  1. 7.1 North America Inhaled Corticosteroid Sales by Country
  2. 7.1.1 North America Inhaled Corticosteroid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhaled Corticosteroid Sales by Country (2021-2026)
  4. 7.1.3 North America Inhaled Corticosteroid Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhaled Corticosteroid Market Size by Country
  6. 7.2.1 North America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhaled Corticosteroid Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhaled Corticosteroid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhaled Corticosteroid Sales by Country
  2. 8.1.1 Europe Inhaled Corticosteroid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhaled Corticosteroid Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhaled Corticosteroid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhaled Corticosteroid Market Size by Country
  6. 8.2.1 Europe Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhaled Corticosteroid Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhaled Corticosteroid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhaled Corticosteroid Sales by Country
  2. 9.1.1 Asia-Pacific Inhaled Corticosteroid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhaled Corticosteroid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhaled Corticosteroid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhaled Corticosteroid Market Size by Country
  6. 9.2.1 Asia-Pacific Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhaled Corticosteroid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhaled Corticosteroid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhaled Corticosteroid Sales by Country
  2. 10.1.1 South America Inhaled Corticosteroid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhaled Corticosteroid Sales by Country (2021-2026)
  4. 10.1.3 South America Inhaled Corticosteroid Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhaled Corticosteroid Market Size by Country
  6. 10.2.1 South America Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhaled Corticosteroid Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhaled Corticosteroid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhaled Corticosteroid Sales by Country
  2. 11.1.1 Middle East and Africa Inhaled Corticosteroid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhaled Corticosteroid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhaled Corticosteroid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhaled Corticosteroid Market Size by Country
  6. 11.2.1 Middle East and Africa Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhaled Corticosteroid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhaled Corticosteroid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhaled Corticosteroid Value Chain Analysis
  2. 12.1.1 Inhaled Corticosteroid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhaled Corticosteroid Production Mode & Process
  7. 12.2 Inhaled Corticosteroid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhaled Corticosteroid Distributors
  10. 12.2.3 Inhaled Corticosteroid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst